Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) is a rare form of cancer that starts in the bile ducts inside the liver, leading to symptoms such as jaundice, abdominal pain, and weight loss.
Intrahepatic Cholangiocarcinoma: PUMP IV Trial
We are studying a new chemotherapy method to help prevent liver cancer from coming back after surgery. This trial will also look at side effects and how it affects patients' quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have any extrahepatic disease (cancer spread outside the liver)?
- Are you currently pregnant or breastfeeding?
- Have you had any serious infections that need treatment?
- Are you taking any medications that suppress your immune system?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Amsterdam UMC
Surgery
Amstelveen, Netherlands
Universitair Medisch Centrum Utrecht
Internal medicine / oncology
De Bilt, Netherlands
Maastricht University Medical Center+ (MUMC+)
Surgery
Maastricht, Netherlands
Sponsor: Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.